GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

Symbol: APGE on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$79,957,396	1,059,085	+166,882	+19%	$75.50	Q4 2025
30 Sep 2025	0%	+0%	$35,453,920	892,203	+109,562	+14%	$39.74	Q3 2025
30 Jun 2025	0%	-0%	$33,994,283	782,641	-53,054	-6.3%	$43.44	Q2 2025
31 Mar 2025	0%	+0%	$31,228,312	835,695	+19,582		$37.37	Q1 2025
31 Dec 2024	0%	-0%	$36,978,142	816,113	-7,726	-0.94%	$45.31	Q4 2024
30 Sep 2024	0%	+0%	$48,400,893	823,839	+82,978	+11%	$58.75	Q3 2024
30 Jun 2024	0%	-0%	$29,157,818	740,861	-20,163	-2.6%	$39.36	Q2 2024
31 Mar 2024	0%	+0%	$50,575,628	761,024	+319,552	+72%	$66.46	Q1 2024
31 Dec 2023	0%	+0%	$12,336,008	441,472	+40,236	+10%	$27.94	Q4 2023
30 Sep 2023	0%	+0%	$8,547,402	401,236	+401,236	NEW	$21.30	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.